I think the key here is to focus on the transparency aspect. That makes me think it might be the "Develop iteratively" principle, since that involves regularly reviewing progress with stakeholders.
I'm pretty sure that if Ms. Stanley agrees to the generic, it should have the same active ingredients as the original, but I recall some concerns about the efficacy being not fully proven in some cases.
upvoted 0 times
...
Log in to Pass4Success
Sign in:
Report Comment
Is the comment made by USERNAME spam or abusive?
Commenting
In order to participate in the comments you need to be logged-in.
You can sign-up or
login
Vesta
4 months agoMicaela
4 months agoHildred
4 months agoJosphine
4 months agoAlex
5 months agoTammara
5 months agoRebbecca
5 months agoLeandro
5 months agoJosue
5 months agoAriel
5 months agoTimmy
5 months agoSkye
5 months ago